Education
About Us
Working with TipRanks
Follow Us
ANI Pharmaceuticals Inc (ANIP)
NASDAQ:ANIP
ANIP Stock Chart & Stats
$90.43
<$0.01(0.02%)
At close: 4:00 PM EST
$90.43
<$0.01(0.02%)
Day’s Range― - ―
52-Week Range$52.50 - $99.50
Previous CloseN/A
Volume18.69K
Average Volume (3M)327.05K
Market Cap
$1.96B
Enterprise ValueN/A
Total Cash (Recent Filing)$262.61M
Total Debt (Recent Filing)$322.63M
Price to Earnings (P/E)―
Beta0.38
Next Earnings
Feb 26, 2026EPS Estimate
2.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.04
Shares Outstanding21,688,772
10 Day Avg. Volume467,727
30 Day Avg. Volume327,053
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)2.49
Price to Sales (P/S)1.74
P/FCF Ratio22.69
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$108.60Price Target Upside20.09% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Cortrophin Gel PerformanceCortrophin Gel continued to demonstrate strong performance, with revenues exceeding both FactSet consensus and analyst estimates.
Future Growth PotentialThe addressable market for Cortrophin Gel is larger than previously modeled, offering significant growth opportunities.
Generics Business GrowthANIP delivered another strong quarter of Cortrophin growth, as well as a strong revenue performance from the company's generics business.
Bears Say
Iluvien Revenue ConcernsILUVIEN reported net revenues were lower than anticipated, affected by continued reduced access among Medicare patients.
Revenue Guidance DoubtsInvestors wonder if the $97-103M guide for Iluvien is optimistic given 1H25 revenues of $38M and weakness in the ophthalmology buy-and-bill market.
ANI Pharmaceuticals News
ANIP FAQ
What was ANI Pharmaceuticals Inc’s price range in the past 12 months?
ANI Pharmaceuticals Inc lowest stock price was $52.50 and its highest was $99.50 in the past 12 months.
What is ANI Pharmaceuticals Inc’s market cap?
ANI Pharmaceuticals Inc’s market cap is $1.96B.
When is ANI Pharmaceuticals Inc’s upcoming earnings report date?
ANI Pharmaceuticals Inc’s upcoming earnings report date is Feb 26, 2026 which is in 110 days.
How were ANI Pharmaceuticals Inc’s earnings last quarter?
ANI Pharmaceuticals Inc released its earnings results on Nov 07, 2025. The company reported $2.04 earnings per share for the quarter, beating the consensus estimate of $1.77 by $0.27.
Is ANI Pharmaceuticals Inc overvalued?
According to Wall Street analysts ANI Pharmaceuticals Inc’s price is currently Undervalued.
Does ANI Pharmaceuticals Inc pay dividends?
ANI Pharmaceuticals Inc does not currently pay dividends.
What is ANI Pharmaceuticals Inc’s EPS estimate?
ANI Pharmaceuticals Inc’s EPS estimate is 2.01.
How many shares outstanding does ANI Pharmaceuticals Inc have?
ANI Pharmaceuticals Inc has 21,688,772 shares outstanding.
What happened to ANI Pharmaceuticals Inc’s price movement after its last earnings report?
ANI Pharmaceuticals Inc reported an EPS of $2.04 in its last earnings report, beating expectations of $1.77. Following the earnings report the stock price went up 0.222%.
Which hedge fund is a major shareholder of ANI Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in ANIP
ANI Pharmaceuticals Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$108.60 (20.09% Upside)
$108.60 (20.09% Upside)
Blogger Sentiment
Bullish
ANIP Sentiment 80%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 184.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $35.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 14.4%
Last 30 Days ▲ 14.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
54.89%
12-Months-Change
Fundamentals
Return on Equity
-2.82%
Trailing 12-Months
Asset Growth
45.86%
Trailing 12-Months
Company Description
ANI Pharmaceuticals Inc
ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The company primarily operates in the areas of niche and complex pharmaceuticals, with a portfolio that includes a wide range of products such as oral solid dosage forms, injectables, and complex formulations. ANI Pharmaceuticals is dedicated to addressing unmet medical needs and enhancing patient care through innovative drug delivery and therapeutic solutions.
ANIP Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong performance by ANI Pharmaceuticals, with record-breaking revenue and significant growth driven by the Rare Disease and Generics segments. Despite challenges in the ILUVIEN segment and Medicare funding affecting Retina products, the company raised its financial guidance and demonstrated robust cash flow and debt management.View all ANIP earnings summariesANIP Stock 12 Month Forecast
Average Price Target
$108.60
▲(20.09% Upside)
Technical Analysis
Avadel Pharmaceuticals
―
Pacira Pharmaceuticals
―
Supernus Pharmaceuticals
―
Amphastar Pharmaceuticals
―
Harrow Health
―
Ownership Overview
8.87% Insiders
20.19% Mutual Funds
0.38% Other Institutional Investors
50.67% Public Companies and
Individual Investors